Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

August 30, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-June 2023

Read press release
August 23, 2023

Invitation to Immunovia’s Q2 presentation

Read press release
July 19, 2023

Immunovia announces updated financial calendar

Read press release
July 11, 2023 | REGULATORY

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

Read press release
June 9, 2023

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares

Read press release
May 31, 2023 | REGULATORY

Change in number of shares and votes in Immunovia AB (publ)

Read press release
May 26, 2023 | REGULATORY

Bulletin from the Annual General Meeting in Immunovia AB

Read press release
May 23, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-March 2023

Read press release
May 22, 2023 | REGULATORY

Changes to the Nomination Committee’s proposal to the Annual General Meeting 2023 in Immunovia AB (publ)

Read press release
May 17, 2023

Invitation to Immunovia’s Q1 presentation

Read press release
May 6, 2023 | REGULATORY

The board member Philipp von Hugo resigns from Immunovia’s board at his own request

Read press release
April 29, 2023 | REGULATORY

Immunovia AB appoints new CEO

Read press release
1 2 3 … 26
Home Press releases